Please login to the form below

Not currently logged in
Email:
Password:

Harren Jhoti and Will West join BIA board

UK biotech trade body welcomes CEOs of Astex Pharmaceuticals and CellCentric

The UK's BioIndustry Association (BIA) has appointed Harren Jhoti, CEO of Astex Pharmaceuticals, and Will West, CEO of CellCentric, to its board of directors.

They take over from Andrew Heath, managing director of Morvus, and Dominique Kleyn, CEO of London Genetics, who will stand down at the end of 2012.

The BIA, which represents the country's bioscience industry, also re-appointed Allan Marchington, partner at Apposite Capital, to the board.

All appointments will serve from January 1, 2013, for a term of two years.

Tim Edwards, BIA chairman, said: “As a result of these appointments, I believe our board continues to broaden its outlook and experience, and I look forward to working with them and the BIA team to ensure the UK remains a world-leading location for the life sciences.”

10th October 2012

From: Research

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

The gene therapy revolution
Gene therapies are bringing new hope for many people with diseases caused by genetic disorders...
PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...

Infographics